Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.35% |
| 3 | Industrials | 11.13% |
| 4 | Consumer Discretionary | 10.88% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Dare Bioscience
DARE
$18.3M
| $18.6K | ﹤0.01% |
10,195
-9,100
| -47% | -$15.6K |
|
3177
BeyondSpring
BYSI
$46.5M
| $18.2K | ﹤0.01% |
11,100
+100
| +0.9% | +$154 |
|
|
PW
3178
Power REIT
PW
$3.31M
| $17.5K | ﹤0.01% |
2,062
-160
| -7% | -$1.42K |
|
|
IPST
3179
IP Strategy Holdings
IPST
$1.75M
| $17.2K | ﹤0.01% |
+3,260
| New | +$60K |
|
3180
BioCardia
BCDA
$13.5M
| $16.8K | ﹤0.01% |
+13,900
| New | +$17.4K |
|
3181
Fractyl Health
GUTS
$120M
| $16.1K | ﹤0.01% |
35,200
-1,827,851
| -98% | -$1.69M |
|
|
MREO
3182
Mereo BioPharma
MREO
$47.5M
| $16K | ﹤0.01% |
48,400
-145,971
| -75% | -$62.6K |
|
3183
Myomo
MYO
$40.2M
| $15.9K | ﹤0.01% |
+23,600
| New | +$19.3K |
|
|
WYHG
3184
Wing Yip Food Holdings
WYHG
$46.4M
| $15.7K | ﹤0.01% |
9,100
-5,950
| -40% | -$11.6K |
|
3185
NextPlat
NXPL
$16.8M
| $15.4K | ﹤0.01% |
4,140
+980
| +31% | +$5.56K |
|
3186
TDH Holdings
PETZ
$12.4M
| $15K | ﹤0.01% |
12,300
-300
| -2% | -$336 |
|
|
GCDT
3187
Green Circle Decarbonize Technology Limited
GCDT
$6.6M
| $14.5K | ﹤0.01% |
+14,388
| New | +$44K |
|
3188
Matinas BioPharma
MTNB
$1.71M
| $14.3K | ﹤0.01% |
28,570
-400
| -1% | -$250 |
|
3189
Origin Agritech
SEED
$12.3M
| $14.2K | ﹤0.01% |
+10,983
| New | +$13K |
|
3190
Southland Holdings
SLND
$34.8M
| $13.4K | ﹤0.01% |
+10,300
| New | +$18.5K |
|
3191
RenovoRx
RNXT
$39M
| $13.1K | ﹤0.01% |
13,000
-104,457
| -89% | -$101K |
|
3192
Lexaria Bioscience
LEXX
$13.9M
| $12.7K | ﹤0.01% |
16,300
+700
| +4% | +$508 |
|
|
MAMO
3193
Massimo Group
MAMO
$42.1M
| $12.6K | ﹤0.01% |
+12,600
| New | +$23.9K |
|
3194
CLPS Inc
CLPS
$26.7M
| $11.5K | ﹤0.01% |
13,032
-100
| -0.8% | -$102 |
|
|
PRHI
3195
Presurance Holdings
PRHI
$19.8M
| $11.3K | ﹤0.01% |
3,181
-462
| -13% | -$2.21K |
|
|
HCWC
3196
Healthy Choice Wellness
HCWC
$5.22M
| $10.8K | ﹤0.01% |
43,300
+28,200
| +187% | +$8.1K |
|
3197
VYNE Therapeutics
VYNE
$30M
| $10.3K | ﹤0.01% |
+17,300
| New | +$10.1K |
|
|
TRIB
3198
Trinity Biotech
TRIB
$6.14M
| $9.63K | ﹤0.01% |
17,762
-2,500
| -12% | -$1.84K |
|
|
APM
3199
DELISTED
Aptorum Group
APM
| $9.42K | ﹤0.01% |
+1,184
| New | +$10.7K |
|
|
JZ
3200
Jianzhi Education Technology Group
JZ
$5.47M
| $9.39K | ﹤0.01% |
+367
| New | +$10.3K |
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.